2BEUERS U, GERSHWIN ME, GISH RG, et al. Changing no- menclature for PBC. From ' cirrhosis' to ' cholangitis' I- J ]. Gut, 2015, 64(11), 1671 -1672.
3CHUANG N, GROSS RG, ODIN JA. Update on the epidemi- ology of primary biliary cirrhosis [ J ]. Expert Rev Gastroen- terol Hepatol, 2011, 5(5), 583-590.
4JIANG XH, ZHONG RQ, FAN XY, et al. Characterization of M2 antibodies in asymptomatic Chinese population [ J ]. World J Gastroenterol, 2003, 9(91 : 2128 -2131 .
5LIU H, LIU Y, WANG L, et al. Prevalence of primary biliary cir- rhosis in adults referring hospital for annual health check -up in Southern China[J]. BMC Gastroenterol, 2010, 10, 100.
6MAYO MJ. Natural history of primary biliary cirrhosis[J]. Clin Uver Dis, 2008, 12(2) : 277 -288.
7PRINCE M, CHETWYND A, NEWMAN W, et al. Survival and sympotom progression in geogapfically based cohort of patients with primay biliay cirrhosis, follow up for up to 28 years [ J ]. Gastroenterology, 2002, 123 (4) = 1044 - 1051.
8IMAM MH, LINDOR KD. The natural histoy of primay biliay cirrhosis[J]. Semin Liver Dis, 2014, 34(3) ~ 329 -333.
9PAR~:S A, CABALLERiA L, RODI~S J. Excellent long -term survival in patients with primary biliary cirrhosis and biochemi- cal response to ursodeoxycholic acid [ J ]. Gastroenterology, 2006, 130(3) : 715 -720.
10CORPECHOT C, CHAZOUILLC:RES O, POUPON R, et al. Bio- chemical response to ursodeoxycholic acid and long -term prognosis in primary biliary cirrhosis~J~. Hepatology, 2008, 48 (3) : 871 -877.
